Leslie Tari - Jan 12, 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Jan 12, 2023
Transactions value $
-$14,177
Form type
4
Date filed
1/27/2023, 03:33 PM
Previous filing
Sep 13, 2022
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Sale -$14.2K -11.8K -88.84% $1.20 1.48K Jan 12, 2023 By spouse
holding CDTX Common Stock 198K Jan 12, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP") on November 18, 2022.